🔎 Trials Near Me

Inicio › Cánceres de la sangre › Texas

Ensayos clínicos de Cánceres de la sangre en Texas

49 estudios sobre Cánceres de la sangre buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

CD70.CAR for AML and Other CD70+ Leukemias

  • Texas Children's Hospital, Houston
  • The Methodist Hospital, Houston
ReclutandoFase 1
Hasta los 75 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06345027

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • Texas Oncology - Central/South Texas ( Site 8001), Austin
  • Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
  • University of Texas MD Anderson Cancer Center ( Site 0007), Houston
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT03486873

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • y 2 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • Texas Oncology-Austin Midtown, Austin
  • Texas Oncology-Presbyterian Cancer Center, Dallas
  • University of Texas, Houston
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07007312

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Edades de 18 a 39 · Todos los sexos · Actualizado el 10 nov 2026 · NCT04551378

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • Audie L Murphy VA Hospital, San Antonio
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 4 nov 2026 · NCT04242095

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  • MD Anderson Cancer Center - University of Texas, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07572006

Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

  • MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07809906

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • The University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 3
Edades de 18 a 71 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07504458

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Texas Children's Hospital, Houston
ReclutandoEstudio observacional
Edades de 0 a 38 · Todos los sexos · Actualizado el 29 oct 2026 · NCT06131801

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT04728893

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • Mays Cancer Center at UT Health San Antonio, San Antonio
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT05745285

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • The University of TX MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT07424833

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • The University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT07648264

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Md Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT07195916

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT04888338

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Cook Children's Medical Center, Fort Worth
  • y 2 más
ReclutandoFase 3
Edades de 2 a 18 · Todos los sexos · Actualizado el 6 oct 2026 · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • The University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03328078

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

  • M D Anderson Cancer Center, Houston
ReclutandoFase 1 temprana
Edades de 12 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT04744116

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

  • UT MD Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 18 sept 2026 · NCT07743476

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • The University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04996875

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • M D Anderson Cancer Center, Houston
ReclutandoFase 2Se aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 14 sept 2026 · NCT04984551

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • M D Anderson Cancer Center, Houston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT02464696

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

  • M D Anderson Cancer Center, Houston
ReclutandoFase 1
Todas las edades · Todos los sexos · Actualizado el 4 sept 2026 · NCT03425526

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Baylor Scott & White Health, Dallas
  • MD Anderson, Houston
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT04588922

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 21 ago 2026 · NCT01772771

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
  • MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT06001788

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

  • M D Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT05110742

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

  • M D Anderson Cancer Center, Houston
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06184321

Expressive Writing for the Management of Stress in Cancer Survivors

  • M D Anderson Cancer Center, Houston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT04776941

The Impact of COVID-19 on Pulmonary Procedures

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 10 ago 2026 · NCT05022446

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 10 ago 2026 · NCT05108519

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, Irving
  • UT San Antonio Mays Cancer, San Antonio
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06823167

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

  • University of Texas MD Anderson MD Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT06665100

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

  • M D Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 16 jul 2026 · NCT04712539

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Medical City Dallas, Dallas
  • Children's Medical Center Dallas, Dallas
  • Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
  • y 5 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

Improving Comprehensive Care of Cancer Patients

  • Baylor College of Medicine, Houston
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jun 2026 · NCT05323409

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT02074839

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

  • M D Anderson Cancer Center, Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT00991094

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.